Fundraising Fox

Amanda Wooding

Investor

Deputy Head of Ventures at University of Cambridge Enterprise

Cambridge

About

Deputy Head of the Ventures team at Cambridge Enterprise, she has spun out six companies and worked on follow-on rounds and exits, sitting on the boards of PredictImmune and Kalium Health. She previously held business development roles at Acambis and worked with the Wellcome Trust, and holds a PhD in molecular endocrinology from the University of Cambridge.

LinkedIn ↗

Invests in

BiotechDeep Tech

Experience

  1. Cambridge EnterpriseInvestment Directorcurrent2021 — presentCambridge
  2. Cambridge EnterpriseDeputy Head of Life Sciences, Technology Transfer2012 — 2021Cambridge, England, United Kingdom
  3. Cambridge EnterpriseTechnology Manager2009 — 2012
  4. Kalium HealthNon Executive Directorcurrent2020 — presentCambridgeshire, England, United Kingdom
  5. PredictImmuneNon Executive Directorcurrent2017 — presentCambridge, England, United Kingdom
  6. Sphere Fluidics LimitedNon Executive Director2011 — 2017Cambridge, England, United Kingdom
  7. ACAMBIS RESEARCH LIMITEDDirector, Business Development2003 — 2008
  8. Catalyst BioMedicaBusiness Development Manager1999 — 2003London Area, United Kingdom
  9. Ferring PharmaceuticalsPostdoctoral Researcher1997 — 1999City Of Southampton, England, United Kingdom
  10. University of CambridgePostdoctoral Researcher1996 — 1997Cambridge, England, United Kingdom

Education

  1. University of CambridgeDoctor of Philosophy (Ph.D.), Insulin Signalling1993 — 1996

Skills & more

StrategyBiotechnology IndustryBiotechnologyBusiness DevelopmentNew Venture FormationLifesciences1Technology Transfer1Pharmaceutical Industry1

From Amanda's professional profile.

Same school

Also attended University of Cambridge652

Niko BonatsosInvestment Team at General CatalystGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesAnthony PhilippakisInvestor at GV (Google Ventures)Erik NordlanderInvestor at GV (Google Ventures)Nic LowdenInvestor at Moonfire Ventures

+ 646 more

Shared employers

Also worked at Cambridge Enterprise9

Christine MartinHead of Ventures at University of Cambridge EnterpriseChris GibbsInvestment Director (Physical Sciences) at University of Cambridge EnterpriseMegan Meredith-RodriguezInvestment Analyst (Deep Tech) at University of Cambridge EnterprisePiers HorlockInvestment Analyst at University of Cambridge EnterpriseGemma SiddallInvestment Associate (Sustainability) at University of Cambridge EnterpriseTom HallInvestment Director at Martlet Capital

+ 3 more

Also worked at Ferring Pharmaceuticals5

Mirjam Mol-ArtsAdvisory Committee member at Curie CapitalRami SuzukiManaging Director at ARCHIMED JapanKlaus DugiChief Medical Advisor & Venture Partner at +ND CapitalHaider AllegGeneral Partner at Allegory CapitalJames HamiltonManaging Director at Atlanta Seed

Also worked at University of Cambridge107

Masha LevinVenture Partner at One Way VenturesFrancesco PomponiInvestor at Extantia CapitalJonathan RobinsonSenior Independent Director at EMV CapitalPhilip KalikmanAssistant Professor of Real Estate, Finance, & Economics at Joyance PartnersAlex TingDirector of Events & Operations at Pillar VCReshma ShettyCo-Founder, Ginkgo Bioworks & Founding Pillar at Pillar VC

+ 101 more

Investments

Board seats

Kalium Health LimitedPredictImmune LimitedSphere Fluidics Limited

Per the firm's website.

Colleagues at University of Cambridge Enterprise

Chris Gibbs
Investment Director (Physical Sciences) at University of Cambridge Enterprise
Christine Martin
Head of Ventures at University of Cambridge Enterprise
Fatima Kranc
Investment Manager (Life Sciences) at University of Cambridge Enterprise
Gemma Siddall
Investment Associate (Sustainability) at University of Cambridge Enterprise
Loukik Arora
Principal Investment Associate (Life Science) at University of Cambridge Enterprise
Mahesh Santiapillai
Investment Manager (Software and DeepTech) at University of Cambridge Enterprise
Megan Meredith-Rodriguez
Investment Analyst (Deep Tech) at University of Cambridge Enterprise
Piers Horlock
Investment Analyst at University of Cambridge Enterprise